Chronic obstructive pulmonary disease (COPD) is characterized by persistent and progressive airflow limitation, and a new study examined the factors responsible for a high St George’s Respiratory Questionnaire for COPD based on severity of airflow limitation.
Chronic obstructive pulmonary disease (COPD) is characterized by persistent and progressive airflow limitation, and a new study examined the factors responsible for a high St George’s Respiratory Questionnaire for COPD (SGRQ-C) based on severity of airflow limitation.
The study, published in the International Journal of COPD, included 1264 patients who were categorized into 2 groups based on the severity of airflow limitation: mild-to-moderate COPD and severe-to-very severe COPD.
“The substantial symptomatic burden of COPD reduces physical and psychological functioning, ultimately decreasing health-related quality of life (HRQoL),” explained the authors.
They sought to analyze the SGRQ-C, which is used to grade symptoms, to identify factors associated with a high score in patients with stable COPD based on the severity of airflow limitation.
The study selected patients in the Korean COPD Subgroup Study cohort and recorded a variety of data, including age, sex, height, weight, smoking status, comorbidities, 6-minute walk distance, cough, sputum, and SGRQ-C score. Of the 902 patients who had mild-to-moderate COPD, 534 (59.2%) had a high SGRQ-C score, and of the 362 patients with severe-to-very severe COPD, 261 (80.4%) had a high SGRQ-C score.
Compared with patients with a low SGRQ-C score, patients with mild-to-moderate COPD and a high score were more likely to be less educated, have more comorbidities, and suffer from more respiratory symptoms, such as cough, sputum, and dyspnea. These patients also had a “significantly lower level” of exercise capacity as determined by the 6-minute walk distance.
Patients with severe-to-very severe COPD and a high score were more likely to have a lower body mass index, a history of pneumonia, osteoporosis, and respiratory symptoms, such as cough, sputum, and dyspnea. Similar to patients with mild-to-moderate COPD, this group had a significantly shorter 6-minute walk distances compared with similar patients with a low SGRQ-C score. No comorbidities were associated with a high score for this group.
Overall, the researchers found a negative correlation between HRQoL and severity of airflow limitation. The fact that only respiratory symptoms were significantly associated with a high SGRQ-C score “indicates the need for an improved management strategy for relieving respiratory symptoms in COPD patients with poor HRQoL,” the authors concluded.
Study: SGLT2is Should Be Continued Despite Initial eGFR Decline in Patients With HFmrEF/HFpEF
December 6th 2023Despite an initial drop in estimated glomerular filtration rate (eGFR) after 1 month of dapagliflozin, researchers say this is not associated with subsequent risk of cardiovascular or kidney events for patients with heart failure with mildly reduced ejection fraction (HFmrEF) or preserved ejection fraction (HFpEF).
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Exclusive Telemedicine Use Linked to Less Favorable Glycemic Outcomes for T2D Endocrinology Care
December 6th 2023Adults with type 2 diabetes (T2D) undergoing endocrinology care are more likely to experience less favorable hemoglobin A1c improvements if they only use telemedicine compared with patients using in-person care or a mix of both.
Read More
Study: SGLT2is Should Be Continued Despite Initial eGFR Decline in Patients With HFmrEF/HFpEF
December 6th 2023Despite an initial drop in estimated glomerular filtration rate (eGFR) after 1 month of dapagliflozin, researchers say this is not associated with subsequent risk of cardiovascular or kidney events for patients with heart failure with mildly reduced ejection fraction (HFmrEF) or preserved ejection fraction (HFpEF).
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Exclusive Telemedicine Use Linked to Less Favorable Glycemic Outcomes for T2D Endocrinology Care
December 6th 2023Adults with type 2 diabetes (T2D) undergoing endocrinology care are more likely to experience less favorable hemoglobin A1c improvements if they only use telemedicine compared with patients using in-person care or a mix of both.
Read More
2 Clarke Drive
Cranbury, NJ 08512